IL286685A - New compounds and their pharmaceutical preparations for the treatment of inflammatory disorders - Google Patents

New compounds and their pharmaceutical preparations for the treatment of inflammatory disorders

Info

Publication number
IL286685A
IL286685A IL286685A IL28668521A IL286685A IL 286685 A IL286685 A IL 286685A IL 286685 A IL286685 A IL 286685A IL 28668521 A IL28668521 A IL 28668521A IL 286685 A IL286685 A IL 286685A
Authority
IL
Israel
Prior art keywords
treatment
pharmaceutical compositions
novel compounds
inflammatory disorders
disorders
Prior art date
Application number
IL286685A
Other languages
English (en)
Hebrew (he)
Original Assignee
Galapagos Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galapagos Nv filed Critical Galapagos Nv
Publication of IL286685A publication Critical patent/IL286685A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL286685A 2019-03-29 2021-09-26 New compounds and their pharmaceutical preparations for the treatment of inflammatory disorders IL286685A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1904374.4A GB201904374D0 (en) 2019-03-29 2019-03-29 Novel compunds and pharmaceutical composistions thereof for the treatment of inflammatory disorders
PCT/EP2020/058063 WO2020200899A1 (en) 2019-03-29 2020-03-24 Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Publications (1)

Publication Number Publication Date
IL286685A true IL286685A (en) 2021-10-31

Family

ID=66443107

Family Applications (1)

Application Number Title Priority Date Filing Date
IL286685A IL286685A (en) 2019-03-29 2021-09-26 New compounds and their pharmaceutical preparations for the treatment of inflammatory disorders

Country Status (14)

Country Link
US (1) US20220194938A1 (cg-RX-API-DMAC7.html)
EP (1) EP3947377A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022526176A (cg-RX-API-DMAC7.html)
KR (1) KR20210143904A (cg-RX-API-DMAC7.html)
CN (1) CN113677679A (cg-RX-API-DMAC7.html)
AU (1) AU2020254882A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021019110A2 (cg-RX-API-DMAC7.html)
CA (1) CA3134735A1 (cg-RX-API-DMAC7.html)
GB (1) GB201904374D0 (cg-RX-API-DMAC7.html)
IL (1) IL286685A (cg-RX-API-DMAC7.html)
MX (1) MX2021011575A (cg-RX-API-DMAC7.html)
PH (1) PH12021552376A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202110678UA (cg-RX-API-DMAC7.html)
WO (1) WO2020200899A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201904373D0 (en) * 2019-03-29 2019-05-15 Galapagos Nv Novel compounds and pharamaceutical compositions thereof for the treatment of inflammatory disorders
GB201904375D0 (en) * 2019-03-29 2019-05-15 Galapagos Nv Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
WO2023098857A1 (zh) * 2021-12-03 2023-06-08 武汉人福创新药物研发中心有限公司 Irak4抑制剂及其用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005016928A1 (ja) * 2003-08-15 2005-02-24 Banyu Pharmaceutical Co., Ltd. イミダゾピリジン誘導体
US7566781B2 (en) * 2004-05-10 2009-07-28 Banyu Pharmaceutical Co., Ltd. Imidazopyridine compound
CA2992406A1 (en) * 2015-07-15 2017-01-19 Aurigene Discovery Technologies Limited Indazole and azaindazole compounds as irak-4 inhibitors
WO2017207386A1 (de) * 2016-06-01 2017-12-07 Bayer Pharma Aktiengesellschaft Verwendung von 2-substituierten indazolen zur behandlung und prophylaxe von autoimmunerkrankungen
WO2018060174A1 (de) * 2016-09-29 2018-04-05 Bayer Pharma Aktiengesellschaft Substituierte benzimidazole, pharmazeutische präparate diese enthaltend, sowie deren verwendung zur herstellung von arzneimitteln
WO2018060072A1 (de) * 2016-09-29 2018-04-05 Bayer Pharma Aktiengesellschaft Neue substituierte benzimidazole, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln
CN110835338A (zh) * 2018-08-17 2020-02-25 浙江海正药业股份有限公司 咪唑并吡啶类衍生物及其制备方法和其在医药上的用途
JP7576552B2 (ja) * 2019-01-18 2024-10-31 バイオジェン・エムエイ・インコーポレイテッド イミダゾ[1,2-a]ピリジニル誘導体及び疾患の処置におけるその使用
GB201904373D0 (en) * 2019-03-29 2019-05-15 Galapagos Nv Novel compounds and pharamaceutical compositions thereof for the treatment of inflammatory disorders
GB201904375D0 (en) * 2019-03-29 2019-05-15 Galapagos Nv Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Also Published As

Publication number Publication date
KR20210143904A (ko) 2021-11-29
BR112021019110A2 (pt) 2021-11-30
AU2020254882A1 (en) 2021-11-25
CN113677679A (zh) 2021-11-19
CA3134735A1 (en) 2020-10-08
PH12021552376A1 (en) 2022-09-19
JP2022526176A (ja) 2022-05-23
MX2021011575A (es) 2021-10-13
US20220194938A1 (en) 2022-06-23
GB201904374D0 (en) 2019-05-15
WO2020200899A1 (en) 2020-10-08
SG11202110678UA (en) 2021-10-28
EP3947377A1 (en) 2022-02-09

Similar Documents

Publication Publication Date Title
ZA202110597B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
ZA202002166B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
ZA202004025B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL286677A (en) New compounds and their pharmaceutical preparations for the treatment of inflammatory disorders
IL279397A (en) New compounds and their pharmaceutical preparations for the treatment of diseases
IL255109A0 (en) New dihydropyridoisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders
IL286688A (en) New compounds and their pharmaceutical preparations for the treatment of inflammatory disorders
GB201907558D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB201911868D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201610056D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis
GB201610055D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis
IL287392A (en) New compounds and their pharmaceutical preparations for the treatment of kidney diseases
GB201904374D0 (en) Novel compunds and pharmaceutical composistions thereof for the treatment of inflammatory disorders
IL285751A (en) New compounds and their pharmaceutical preparations for the treatment of diseases
GB201702603D0 (en) Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders
HK40068361A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
HK40068861A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
HK40068360A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB202001421D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB202001420D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201807222D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammation disorders
GB201905536D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of metabolic disorders
HK40083625A (en) Pharmaceutical composition for treatment or prevention of multiple inflammatory disorders
GB201817344D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB201817343D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases